ATE256470T1 - Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung - Google Patents

Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung

Info

Publication number
ATE256470T1
ATE256470T1 AT00905120T AT00905120T ATE256470T1 AT E256470 T1 ATE256470 T1 AT E256470T1 AT 00905120 T AT00905120 T AT 00905120T AT 00905120 T AT00905120 T AT 00905120T AT E256470 T1 ATE256470 T1 AT E256470T1
Authority
AT
Austria
Prior art keywords
medication
fragments
production
hyaluronic acid
hematopoietic differentiation
Prior art date
Application number
AT00905120T
Other languages
English (en)
Inventor
Florence Smadja-Joffe
Rachida-Sihem Charrad
Christine Chomienne
Bertrand Delpech
Claude Jasmin
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE256470T1 publication Critical patent/ATE256470T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pyrrole Compounds (AREA)
  • External Artificial Organs (AREA)
  • Basic Packing Technique (AREA)
AT00905120T 1999-02-11 2000-02-11 Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung ATE256470T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9901644A FR2789587B1 (fr) 1999-02-11 1999-02-11 Moyens pour la regulation de la differenciation hematopoietique
PCT/FR2000/000349 WO2000047163A2 (fr) 1999-02-11 2000-02-11 Utilisation de l'acide hyaluronique ou des fragments de celle-ci pour la regulation de la differenciation hematopoietique

Publications (1)

Publication Number Publication Date
ATE256470T1 true ATE256470T1 (de) 2004-01-15

Family

ID=9541894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905120T ATE256470T1 (de) 1999-02-11 2000-02-11 Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung

Country Status (8)

Country Link
EP (1) EP1150692B1 (de)
AT (1) ATE256470T1 (de)
AU (1) AU2676200A (de)
CA (1) CA2362707A1 (de)
DE (1) DE60007278T2 (de)
ES (1) ES2212984T3 (de)
FR (1) FR2789587B1 (de)
WO (1) WO2000047163A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2167251B1 (es) * 2000-07-13 2003-09-16 Bioiberica Nuevos disacaridos con accion antiartrosica.
AUPR856501A0 (en) 2001-10-30 2001-11-29 Peter Maccallum Cancer Institute, The Detection of haematopoietic stem cells and progeny and uses thereof
EP2384759A1 (de) * 2010-05-06 2011-11-09 Suomen Punainen Risti Veripalvelu Sulfatierte Hyaluronsäure in Kombination mit G-CSF für den Einsatz bei der Mobilisierung von Blutstammzellen
US8546353B2 (en) 2010-05-06 2013-10-01 Glykos Finland Oy Compounds and combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240098A3 (de) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
WO1996016973A1 (fr) * 1994-12-01 1996-06-06 Seikagaku Corporation Fraction d'oligosaccharide de sulfate de keratane et medicament la contenant
DE19802540C1 (de) * 1998-01-23 1998-11-19 Univ Ludwigs Albert Verfahren zur Herstellung von dendritischen Zellen mit niedermolekularen Fragmenten der Hyaluronsäure

Also Published As

Publication number Publication date
FR2789587A1 (fr) 2000-08-18
CA2362707A1 (fr) 2000-08-17
WO2000047163A3 (fr) 2001-04-26
EP1150692B1 (de) 2003-12-17
WO2000047163A2 (fr) 2000-08-17
AU2676200A (en) 2000-08-29
FR2789587B1 (fr) 2003-01-24
ES2212984T3 (es) 2004-08-16
EP1150692A2 (de) 2001-11-07
DE60007278D1 (de) 2004-01-29
DE60007278T2 (de) 2004-09-16

Similar Documents

Publication Publication Date Title
Dahiya et al. Hyaluronic acid: a boon in periodontal therapy
Evered et al. The biology of hyaluronan
Maytin Hyaluronan: More than just a wrinkle filler
Moseley et al. Hyaluronan and its potential role in periodontal healing
Kogan et al. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications
Laterra et al. Differences in hyaluronate binding to plasma and cell surface fibronectins. Requirement for aggregation
DE60210752D1 (de) Pharmazeutische zusammensetzung enthaltend proteoglykan und ihre verwendung zur behandlung von entzündlichen erkrankungen
CN101501075B (zh) 支化透明质酸和制造方法
RU2016119532A (ru) Производство рекомбинантного лубрицина
Wu et al. Effects of exogenous glycosaminoglycans on human chondrocytes cultivated on type II collagen scaffolds
Schiller et al. Hyaluronic acid: a natural biopolymer
SE9704003L (sv) Formkroppar för användning som implantat i humanmedicin samt förfarande för framställning av sådana formkroppar
ATE256470T1 (de) Verwendung von hyaluronsäure oder fragmenten davon zur herstellung eines medikamentes zur regelung der hämatopoietischen differenzierung
Wiest et al. Native hyaluronic acid in dermatology–results of an expert meeting
PH27214A (en) N-2,3-butadienyl tri and tetraaminoalkane derivatives
Kolset Oversulfated chondroitin sulfate proteoglycan in cultured human peritoneal macrophages
Edward et al. Human melanoma cell‐derived factor (s) stimulate fibroblast glycosaminoglycan synthesis
CN105873955B (zh) 富氘透明质酸
Bertolesi et al. Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins
Bartold et al. Isolation, identification, and quantitation of glycosaminoglycans synthesized by human gingival fibroblasts in vitro
Lambe et al. Isolation, purification and characterization of hyaluronic acid: a concise review
Gümüş et al. Hyaluronic acid dermal filler promotes cartilage reshaping in rabbit ears
Orlińska et al. Glycosaminoglycans–types, structure, functions, and the role in wound healing processes
DE212020000715U1 (de) Hydrogel auf der Basis eines vernetzten Hydroxyphenylderivats der Hyaluronsäure
Torres et al. Nerve growth factor effect on adenosine transport in cultured chromaffin cells

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1150692

Country of ref document: EP

REN Ceased due to non-payment of the annual fee